PATIENTS WITH PSORIATIC ARTHRITIS (PSA) TREATED WITH ADALIMUMAB ACHIEVED CLINICAL REMISSION AND GOOD CLINICAL RESPONSES IN THE STEREO TRIAL

被引：0
|
作者：
Reece, Richard [5 ]
Van den Bosch, Filip [1 ]
Manger, Bernhard [2 ]
Goupille, Philippe [3 ]
Kron, Martina [4 ]
Kary, Sonja [4 ]
Kupper, Hartmut [4 ]
机构：
[1] Univ Hosp, Ghent, Belgium
[2] Univ Erlangen Nurnberg, Erlangen, Germany
[3] Univ Hosp, Tours, France
[4] Abbott GmbH & Co KG, Ludwigshafen, Germany
[5] Calderdale & Huddersfield NHS Fdn Trust, Leeds, W Yorkshire, England
来源：
RHEUMATOLOGY | 2009年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I55 / I56
页数：2
相关论文
共 50 条
  • [31] Psoriatic arthritis (PsA) in Canadian Clinical Practice: the PsA Assessment in Rheumatology (PAIR)
    Gladman, Dafna
    Chandran, Vinod
    Thavaneswaran, Arane
    Zummer, Michel
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1162 - 1162
  • [32] Sensivity and Specificity of Clinical Criteria to Identify Patients in Ultrasound Remission in Psoriatic Arthritis
    Michelsen, Brigitte
    Diamantopoulos, Andreas P.
    Hammer, Hilde Berner
    Kavanaugh, Arthur
    Haugeberg, Glenn
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ETANERCEPT (WITH AND WITHOUT METHOTREXATE) IN ROUTINE CLINICAL PRACTICE AS COMPARED TO A CLINICAL TRIAL EXPERIENCE
    Keystone, E. C.
    Cannon, G. W.
    Wang, B. C.
    Park, G. S.
    Koenig, A.
    Collier, D. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 364 - 364
  • [34] LOW INFLAMMATION ON MAGNETIC RESONANCE IMAGING IN PATIENTS WITH RHEUMATOID ARTHRITIS THAT ACHIEVED SUSTAINED CLINICAL REMISSION ON ADALIMUMAB: DATA FROM THE PREDICTRA STUDY
    Emery, P.
    Burmester, G.
    Naredo, E.
    Lagunes, I.
    Zhang, Y.
    Wang, X.
    Hojnik, M.
    Conaghan, P. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 283 - 284
  • [35] Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
    Wcislo-Dziadecka, Dominika
    Grabarek, Benjamin
    Swinarew, Andrzej S.
    Rozwadowska, Beata
    Zmarzly, Nikola
    Gola, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (02): : 262 - 268
  • [36] Psoriatic Arthritis in Canadian Clinical Practice: The PsA Assessment in Rheumatology
    Gladman, Dafna D.
    Chandran, Vinod
    Thavaneswaran, Arane
    Zummer, Michel
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (09) : 1850 - 1853
  • [37] EFFECTIVE TREATMENT FOR JOINT AND SKIN SYMPTOMS WITH ADALIMUMAB IN COMBINATION WITH VARIOUS DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) IN PATIENTS WITH PSORIATIC ARTHRITIS (PsA): RESULTS OF THE STEREO TRIAL
    McHugh, Neil
    van den Bosch, Filip
    Roedevand, Erik
    Holck, Palle
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    RHEUMATOLOGY, 2009, 48 : I6 - I7
  • [38] Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis
    van Kuijk, A. W. R.
    de Groot, M.
    Stapel, S. O.
    Dijkmans, B. A. C.
    Wolbink, G. J.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 624 - U187
  • [39] ANTI CITRULLINATED PEPTIDE ANTIBODY (ACPA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): CLINICAL RELEVANCE
    Huynh, D.
    Etzel, C.
    Cox, V.
    Kremer, J.
    Greenberg, J.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 673 - 673
  • [40] THE IMMUNOGENICITY OF BIOLOGICAL THERAPIES CORRELATES WITH CLINICAL EFFICACY IN PSORIATIC ARTHRITIS (PSA) IN LONG-TERM TREATMENT WITH INFLIXIMAB AND ADALIMUMAB
    Cajigas, D.
    Plasencia, C.
    Pascual-Salcedo, D.
    Bonilla, G.
    Alcocer, P.
    Garcia-Carazo, S.
    Franco, K. N.
    Lojo, L.
    Nuno, L.
    Villalba, A.
    Peiteado, D.
    Ramiro, S.
    Lopez-Casla, M. T.
    Diez, J.
    Martin-Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 964 - 965
12345